1. Home
  2. BWAY vs CYRX Comparison

BWAY vs CYRX Comparison

Compare BWAY & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$16.49

Market Cap

450.8M

Sector

Health Care

ML Signal

HOLD

CYRX

CryoPort Inc.

HOLD

Current Price

$10.55

Market Cap

419.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BWAY
CYRX
Founded
2003
1999
Country
Israel
United States
Employees
N/A
1100
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
450.8M
419.3M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
BWAY
CYRX
Price
$16.49
$10.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
8
Target Price
$13.25
$13.31
AVG Volume (30 Days)
144.8K
409.4K
Earning Date
05-12-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
156.22
EPS
N/A
1.40
Revenue
N/A
$176,177,000.00
Revenue This Year
$309.69
$11.06
Revenue Next Year
$26.21
$8.45
P/E Ratio
$81.98
$7.28
Revenue Growth
N/A
N/A
52 Week Low
$8.59
$5.31
52 Week High
$26.63
$11.45

Technical Indicators

Market Signals
Indicator
BWAY
CYRX
Relative Strength Index (RSI) 59.22 68.70
Support Level $14.56 $9.18
Resistance Level $16.63 $11.33
Average True Range (ATR) 0.71 0.41
MACD 0.41 0.08
Stochastic Oscillator 95.83 82.83

Price Performance

Historical Comparison
BWAY
CYRX

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

About CYRX CryoPort Inc.

CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.

Share on Social Networks: